Literature DB >> 6993266

Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man.

D S Schade, R P Eaton, N M Friedman, W J Spencer.   

Abstract

This study examined the feasibility of normalizing the plasma insulin profile in five insulin deficient diabetic males. Acute meal-related increases in plasma free insulin concentration were achieved by administering short-acting insulin intraperitoneally with a pre-programmed portable rotary splenoid driven pump. This insulin response was compared to that achieved when short-acting insulin was injected subcutaneously 15 minutes prior to each meal. After intraperitoneal insulin maximal plasma free insulin concentration was observed within 45 minutes of administration, and averaged 40 +/- 13 mU/l(+/- SEM) for breakfast, 30 +/- 13 mU/l for lunch, and 36 +/- 13 mU/l for supper. This acute rise was followed by a gradual decline in plasma free insulin concentration, simulating a normal plasma insulin profile. With subcutaneously injected insulin, approximately the same maximal plasma free insulin concentration was obtained as observed with intraperitoneal insulin, but it was delayed 116 minutes following injection. These data suggest that intraperitoneally delivered insulin is rapidly absorbed and may normalize the peripheral plasma free insulin concentration, at least during short-term studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993266     DOI: 10.1007/bf00258308

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Dose response to insulin in man: differential effects on glucose and ketone body regulation.

Authors:  D S Schade; R P Eaton
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

2.  Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects.

Authors:  M Ahmed; M C Gannon; F Q Nuttall
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

3.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

4.  Plasma insulin and glucose profiles in normal, obese, and diabetic persons.

Authors:  S M Genuth
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

5.  The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man.

Authors:  D S Schade; R P Eaton; N Friedman; W Spencer
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

6.  The peritoneum--a potential insulin delivery route for a mechanical pancreas.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

7.  Regulation of brittle diabetics by a pre-planned insulin infusion programme.

Authors:  T Deckert; B Lorup
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

8.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

9.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

10.  Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery.

Authors:  D S Schade; R P Eaton; W Spencer
Journal:  Diabetes Care       Date:  1980 Jan-Feb       Impact factor: 19.112

View more
  17 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Oral Insulin Delivery in a Physiologic Context: Review.

Authors:  Ehud Arbit; Miriam Kidron
Journal:  J Diabetes Sci Technol       Date:  2017-02-02

Review 3.  Development of glucose-responsive 'smart' insulin systems.

Authors:  Nischay K Rege; Nelson F B Phillips; Michael A Weiss
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-08       Impact factor: 3.243

Review 4.  Oral insulin: the rationale for this approach and current developments.

Authors:  Ehud Arbit; Miriam Kidron
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Intermittent hyperinsulinaemia and arterial glycosaminoglycans in dogs.

Authors:  O V Sirek; A Sirek; E Cukerman
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

6.  Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation.

Authors:  Siang Ing Lee; Parth Narendran
Journal:  BMJ Case Rep       Date:  2014-08-21

7.  Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy.

Authors:  A Cimino; U Valentini; A Rotondi; R Candrina; A Salvi; S Spandrio; E Radaeli; G Giustina
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

8.  A New Optimized Percutaneous Access System for CIPII.

Authors:  Rosa Garcia-Verdugo; Michael Erbach; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2017-03-01

9.  Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.

Authors:  J T Jimenez; S Walford; P D Home; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

10.  Subcutaneous versus intraperitoneal administration of insulin on post-prandial hyperglycaemia and glucose turnover in alloxan diabetic dogs.

Authors:  R A Rizza; R E Westland; L D Hall; G Patton; M W Haymond; A H Clemens; J E Gerich; F J Service
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.